Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rockwell Medical (RMTI) Change in Cash (2016 - 2025)

Rockwell Medical's Change in Cash history spans 16 years, with the latest figure at -$2.9 million for Q4 2025.

  • For Q4 2025, Change in Cash fell 187.21% year-over-year to -$2.9 million; the TTM value through Dec 2025 reached -$5.0 million, down 174.13%, while the annual FY2025 figure was -$5.0 million, 174.13% down from the prior year.
  • Change in Cash reached -$2.9 million in Q4 2025 per RMTI's latest filing, down from $1.1 million in the prior quarter.
  • In the past five years, Change in Cash ranged from a high of $20.9 million in Q2 2022 to a low of -$17.8 million in Q3 2022.
  • Average Change in Cash over 5 years is -$1.9 million, with a median of -$2.1 million recorded in 2023.
  • Peak YoY movement for Change in Cash: skyrocketed 732.88% in 2022, then tumbled 395.58% in 2024.
  • A 5-year view of Change in Cash shows it stood at -$10.1 million in 2021, then soared by 71.53% to -$2.9 million in 2022, then soared by 142.53% to $1.2 million in 2023, then skyrocketed by 171.57% to $3.3 million in 2024, then crashed by 187.21% to -$2.9 million in 2025.
  • Per Business Quant, the three most recent readings for RMTI's Change in Cash are -$2.9 million (Q4 2025), $1.1 million (Q3 2025), and $1.1 million (Q2 2025).